Abstract
The transcription factor Foxp3 is indispensible for the differentiation and function of regulatory T cells (Treg cells). To gain insights into the molecular mechanisms of Foxp3-mediated gene expression, we purified Foxp3 complexes and explored their composition. Biochemical and mass-spectrometric analyses revealed that Foxp3 forms multiprotein complexes of 400–800 kDa or larger and identified 361 associated proteins, ∼30% of which were transcription related. Foxp3 directly regulated expression of a large proportion of the genes encoding its cofactors. Some transcription factor partners of Foxp3 facilitated its expression. Functional analysis of the cooperation of Foxp3 with one such partner, GATA-3, provided additional evidence for a network of transcriptional regulation afforded by Foxp3 and its associates to control distinct aspects of Treg cell biology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Josefowicz, S.Z., Lu, L.F., Rudensky, A.Y. & Regulatory, T. Cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–564 (2012).
Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775–787 (2008).
Godfrey, V.L., Wilkinson, J.E. & Russell, L.B. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138, 1379–1387 (1991).
Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20–21 (2001).
Wildin, R.S. & Freitas, A. IPEX and FOXP3: clinical and research perspectives. J. Autoimmun. 25 (suppl.), 56–62 (2005).
Williams, L.M. & Rudensky, A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8, 277–284 (2007).
Marson, A. et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445, 931–935 (2007).
Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936–940 (2007).
Gavin, M.A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771–775 (2007).
Lin, W. et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8, 359–368 (2007).
van der Vliet, H.J. & Nieuwenhuis, E.E. IPEX as a result of mutations in FOXP3. Clin. Dev. Immunol. 2007, 89017 (2007).
Le Bras, S. & Geha, R.S. IPEX and the role of Foxp3 in the development and function of human Tregs. J. Clin. Invest. 116, 1473–1475 (2006).
Ziegler, S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 24, 209–226 (2006).
Li, B. et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. USA 104, 4571–4576 (2007).
Li, B. et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int. Immunol. 19, 825–835 (2007).
Chae, W.J., Henegariu, O., Lee, S.K. & Bothwell, A.L. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc. Natl. Acad. Sci. USA 103, 9631–9636 (2006).
Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375–387 (2006).
Pan, F. et al. Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 325, 1142–1146 (2009).
Ono, M. et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446, 685–689 (2007).
Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299–1307 (2007).
Morkowski, S. et al. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates. J. Exp. Med. 182, 1403–1413 (1995).
de Boer, E. et al. Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 100, 7480–7485 (2003).
Szymczak, A.L. et al. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22, 589–594 (2004).
Chen, Y.I. et al. Proteomic analysis of in vivo-assembled pre-mRNA splicing complexes expands the catalog of participating factors. Nucleic Acids Res. 35, 3928–3944 (2007).
Tyagi, A., Ryme, J., Brodin, D., Ostlund Farrants, A.K. & Visa, N. SWI/SNF associates with nascent pre-mRNPs and regulates alternative pre-mRNA processing. PLoS Genet. 5, e1000470 (2009).
Samstein, R.M. et al. Foxp3 exploits a preexistent enhancer landscape for regulatory T cell lineage specification. Cell (in the press).
Rudra, D. et al. Runx-CBFβ complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10, 1170–1177 (2009).
Kitoh, A. et al. Indispensable role of the Runx1-Cbfβ transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity 31, 609–620 (2009).
Ruan, Q. et al. Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity 31, 932–940 (2009).
Wang, Y., Su, M.A. & Wan, Y.Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337–348 (2011).
Wohlfert, E.A. et al. GATA3 controls Foxp3 regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503–4515 (2011).
Vanvalkenburgh, J. et al. Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease. J. Exp. Med. 208, 2069–2081 (2011).
Mouly, E. et al. The Ets-1 transcription factor controls the development and function of natural regulatory T cells. J. Exp. Med. 207, 2113–2125 (2010).
Xu, L. et al. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 33, 313–325 (2010).
Wei, G. et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity 35, 299–311 (2011).
Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808–812 (2010).
Zhou, Z., Song, X., Li, B. & Greene, M.I. FOXP3 and its partners: structural and biochemical insights into the regulation of FOXP3 activity. Immunol. Res. 42, 19–28 (2008).
Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458, 351–356 (2009).
Dang, E.V. et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146, 772–784 (2011).
Darce, J. et al. An N-terminal mutation of the foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 36, 731–741 (2012).
Bettini, M.L. et al. Loss of epigenetic modification driven by the foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 36, 717–730 (2012).
Klunker, S. et al. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J. Exp. Med. 206, 2701–2715 (2009).
Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986–991 (2009).
Langlais, D., Couture, C., Balsalobre, A. & Drouin, J. The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome. Mol. Cell 47, 38–49 (2012).
Koch, M.A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10, 595–602 (2009).
Pardo, M. et al. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 6, 382–395 (2010).
Rubtsov, Y.P. et al. IL-10 produced by regulatory T cells contributes to their suppressor function by limiting inflammation at environmental interfaces. Immunity 28, 546–558 (2008).
Pai, S.Y. et al. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19, 863–875 (2003).
Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392–8396 (1993).
Acknowledgements
We thank S. Lee, A. Bravo, J. Herlihy and J. Gerard for help with the mouse colony management and technical assistance; I.-C. Ho (Harvard Medical School) for Gata3fl/fl mice, D. Littman (New York University) for Runx1 antibody, I. Taniuchi (RIKEN Research Center for Allergy and Immunology) for Cbfβ andtibody and K. Georgopoulos (Massachusetts General Hospital) for Ikzf1 and Ikzf3 antibodies. This work was supported by US National Institutes of Health R37 AI034206 grant and the Howard Hughes Medical Institute (A.Y.R.). D.R. was supported by Arthritis Foundation postdoctoral fellowship. A.C. is supported by the Irvington Institute Fellowship Program of the Cancer Research Institute. R.E.N. is supported by National Institutes of Health Medical Scientist Training Program grant GM07739 and National Institute of Neurological Disorders and Stroke grant 1F31NS073203-01. R.M.S. is supported by National Institutes of Health DK091968 and Medical Scientist Training Program GM07739 grants.
Author information
Authors and Affiliations
Contributions
D.R. designed and performed the majority of experiments, analyzed data and wrote the manuscript; P.d. performed chromatography and protein purifications, and was involved in mass-spectrometric analysis; A.C. was involved in co-immunoprecipitation studies; R.E.N. was involved in functional analysis of Gata3fl/fl Foxp3-YFP-Cre mice; R.M.S. performed Foxp3 ChIP-seq and gene-expression analyses in Treg and TFN cells; A.A. and C.L. performed computational and statistical analysis of ChIP-Seq and gene expression data sets; S.A.S. and D.R.G. assisted with mass-spectrometric analyses; A.Y.R. directed the project, was involved in design of experiments, data analysis and interpretation, and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8, Supplementary Table 5 (PDF 1450 kb)
Supplementary Table 1
Foxp3-associated proteins in TCli cells and ex vivo isolated Treg cells and cumulative abundance of of Foxp3 associated proteins. (XLSX 67 kb)
Supplementary Table 2
GO term enrichment of the “molecular function” category of Foxp3-associated proteins and GO term enrichment of the “biological process” category of Foxp3-associated proteins. (XLSX 34 kb)
Supplementary Table 3
Foxp3 occupied regions within the gene loci encoding transcription-related Foxp3 interacting proteins. (XLSX 23 kb)
Supplementary Table 4
Genomic regions co-occupied by Foxp3 and Gata3. (XLSX 53 kb)
Rights and permissions
About this article
Cite this article
Rudra, D., deRoos, P., Chaudhry, A. et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol 13, 1010–1019 (2012). https://doi.org/10.1038/ni.2402
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.2402
This article is cited by
-
The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases
Nature Reviews Immunology (2024)
-
What happens to regulatory T cells in multiple myeloma
Cell Death Discovery (2023)
-
Regulatory T cells in the face of the intestinal microbiota
Nature Reviews Immunology (2023)
-
An immune-cell transcription factor tethers DNA together
Nature (2023)
-
Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis
Science China Life Sciences (2023)